• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Briacell Therapeutics Corp (NQ: BCTX )

    0.7370 -0.0245 (-3.22%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 29, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 164,479
    Open 0.7615
    Bid (Size) 0.7392 (1)
    Ask (Size) 0.7608 (11)
    Prev. Close 0.7615
    Today's Range 0.7120 - 0.7615
    52wk Range 0.6012 - 7.590
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    BCTX Stock Earnings: BriaCell Therapeutics Beats EPS for Q3 2024
    BCTX stock results show that BriaCell Therapeutics beat analyst estimates for earnings per share the third quarter of 2024. 
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Pre-market stock movers are a hot topic as investors return to trading on Tuesday following the long holiday weekend! 
    Via InvestorPlace

    Performance

    YTD
    -86.20%
    -86.20%
    1 Month
    -35.35%
    -35.35%
    3 Month
    -65.88%
    -65.88%
    6 Month
    -82.78%
    -82.78%
    1 Year
    -88.98%
    -88.98%

    More News

    Read More
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    BCTX Stock Earnings: BriaCell Therapeutics Reported Results for Q2 2024
    Via InvestorPlace
    BriaCell: An Emerging Immuno - Oncology Company
    Via Talk Markets
    Exposures Product Safety
    New Treatments May Help Those With Advanced Breast Cancer Live Longer
    Via StatePoint Media
    Another BriaCell Therapeutics Goal: A Better Treatment For Prostate Cancer
    Via Talk Markets
    Get Rich Quick With These 3 Penny Stocks to Buy Now
    Via InvestorPlace
    Topics Economy
    Exposures Economy
    BriaCell Therapeutics' Cancer Drug Shows Preliminary Survival, Clinical Benefit In Pretreated Patients
    Via Benzinga
    Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023
    Via FinancialNewsMedia
    Exposures Product Safety
    BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily
    Via NewMediaWire
    BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily
    Via TheNewswire.com
    BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily
    Via NewMediaWire
    Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer
    Via FinancialNewsMedia
    BriaCell Therapeutics' Mission: Destroy Breast & Prostate Cancers
    Via Talk Markets
    BriaCell Announces Positive End of Phase II Meeting with the FDA for Bria-IMT(TM) Combination in Advanced Metastatic Breast Cancer
    Via Talk Markets
    BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
    Via News Direct
    Topics Death
    Exposures Death
    BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
    Via TheNewswire.com
    Topics Death
    Exposures Death
    BriaCell's Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
    Via Benzinga
    BriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
    Via TheNewswire.com
    Topics Stocks
    Exposures Product Safety US Equities
    BriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
    Via News Direct
    Exposures Product Safety
    BriaCell's Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
    Via Benzinga
    IPA’s Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies
    From ImmunoPrecise Antibodies
    Via Business Wire
    Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday
    Via Benzinga
    Why Is BriaCell (BCTX) Stock Moving Today?
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.